NTRA Stock Analysis: Buy, Sell, or Hold?
NTRA - Natera, Inc. Common Stock
$184.50
1.85 (1.01%)
▲
5d:
-7.79%
30d:
-11.32%
90d:
-21.07%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
NTRA is down 6.5% this week, but smart money is accumulating calls. Top strike: $200 2026-05-15 with 1,006 OI. Call ratio: 98% View Scanner →
Strength: 8.0/10
Get Alerted When NTRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NTRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NTRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NTRA is currently trading at $184.50, which is considered oversold relative to its 30-day fair value range of $192.01 to $209.06.
Technical Outlook: Technically, NTRA is in a downtrend. The price is currently testing key support at $189.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $259.11 (+41.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTRA is in a downtrend. The price is currently testing key support at $189.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $259.11 (+41.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$192.01 -
$209.06
Company Quality Score
60/100
(HOLD)
Options IV Signal
38th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
Protect Your Profits
Holding NTRA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 38th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.9% below Wall St target ($259.11)
- CAUTION: Recommendation downgraded due to -7.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$192.01 -
$209.06
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$15.32
(8.3%)
Support & Resistance Levels
Support Level
$189.04
Resistance Level
$204.34
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-257.91
Wall Street Target
$259.11
(+41.9%)
Revenue Growth (YoY)
39.8%
Profit Margin
-9.0%
Share & Embed Analysis
Last updated: March 30, 2026 10:27 AM ET
Data refreshes hourly during market hours. Next update: 11:27 AM
Data refreshes hourly during market hours. Next update: 11:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Rowan E Chapman
SELL
122 shares
2026-03-13
John Fesko
SELL
707 shares
2026-03-10
Michael Burkes Brophy
SELL
785 shares
2026-03-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 58 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$236 | 58 HOLD |
Advanced NTRA Option Strategies
Professional options setups generated by AI based on today's NTRA price and gamma walls.
